FDA Inspection 967738 — Catalent Pharma Solutions, LLC
The FDA completed an inspection of Catalent Pharma Solutions, LLC on Mar 25, 2016 in Saint Petersburg, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 25, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Petersburg, FL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)